Article

Tumor antigens and immunogenic cell death subtypes guided mRNA vaccine development for lower-grade gliomas

2023-10-31

Abstract excerpt

<h4>Background: </h4> Accumulating evidence demonstrated the effectiveness of mRNA vaccine against many cancers, however, their development in LGGs is still urgently needed. In addition, increasing evidence demonstrated that Immunogenic cell death (ICD) was associated with antitumor immune response. Thus, the aim of our study was to identify potential LGG tumor antigens for mRNA vaccine development and select suit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3d96e0f4-d20e-5c70-b88c-7dc2eec656ca
DOI: 10.21203/rs.3.rs-3505524/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Tumor antigens and immunogenic cell death subtypes guided mRNA vaccine development for lower-grade gliomasDOI 10.21203/rs.3.rs-3505524/v1Read

Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine.Semantic proximity Read

Identification of tumor antigens and immune subtypes in lower grade gliomas for mRNA vaccine developmentSemantic proximity Read

Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development.Semantic proximity Read

Tumor antigens and immune subtypes of glioblastoma: the fundamentals of mRNA vaccine and individualized immunotherapy developmentSemantic proximity Read

Predictive Panel for Immunotherapy in Low-Grade Glioma.Semantic proximity Read

Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade gliomaSemantic proximity Read

Diverse cell death signature based subtypes predict the prognosis and immune characteristics within gliomaSemantic proximity Read

Diverse cell death signature based subtypes predict the prognosis and immune characteristics within gliomaSemantic proximity Read

Comprehensive Molecular Analyses of a Novel Mutational Signature Classification System with Regard to Prognosis, Genomic Alterations, and Immune Landscape in GliomaSemantic proximity Read

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade GliomasSemantic proximity Read

Identification of tumor-associated antigens and immune subtypes of lower-grade glioma and glioblastoma for mRNA vaccine developmentSemantic proximity Read

Leveraging a diverse cell-death patterns-based signature to predict the prognosis of low- grade gliomasSemantic proximity Read